Literature DB >> 8817563

Promotion of synthetic amyloid beta-peptide fibrillization by cell culture media and cessation of fibrillization by serum.

J Wegiel1, A Chauhan, H M Wisniewski, J Nowakowski, K C Wang, H Le Vine.   

Abstract

Dulbecco's modified Eagle's medium promotes aggregation and fibrillization of the synthetic amyloid beta 1-40 and beta 1-42 peptides more than RPMI and OPTI media. Fibrillization in all of these media is faster than in phosphate-buffered saline and Tris buffer. Normal and heat-inactivated fetal bovine and human serum abolish amyloid fibril formation in buffers and cell culture media. Fibrillar amyloid formed during 2-day-long incubation in cell culture media and buffers is defibrillized by 1-day-long treatment with human and bovine serum. This study indicates that amyloid beta fibrillogenesis in cell culture should be studied in serum-free media or in media with a low concentration of serum.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8817563     DOI: 10.1016/0304-3940(96)12739-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Metal cations defibrillize the amyloid beta-protein fibrils.

Authors:  V P Chauhan; I Ray; A Chauhan; J Wegiel; H M Wisniewski
Journal:  Neurochem Res       Date:  1997-07       Impact factor: 3.996

2.  Media from rhabdomyosarcoma and neuroblastoma cell cultures stimulate in vitro aggregation and fibrillization of amyloid beta-protein.

Authors:  A Chauhan; V P Chauhan; R Rubenstein; J Wegiel; H M Wisniewski
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

3.  Search for amyloid-binding proteins by affinity chromatography.

Authors:  Miguel Calero; Agueda Rostagno; Jorge Ghiso
Journal:  Methods Mol Biol       Date:  2012

4.  Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice.

Authors:  Paul T Jantzen; Karen E Connor; Giovanni DiCarlo; Gary L Wenk; John L Wallace; Amyn M Rojiani; Domenico Coppola; Dave Morgan; Marcia N Gordon
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.